top of page

Current Projects & Grants

The Center is currently conducting several research projects funded as a Biomarker Developmental Laboratory and a Biomarker Reference Laboratory under the NCI EDRN. Our research also includes technology development and biomarker discovery projects for the Johns Hopkins Proteomic Innovation Center in Heart Failure of NHLBI led by Dr. Jennifer Van Eyk (Cardiology). We are also conducting proteomics research associated with the Programs of Excellence in Glycosciences (PEG) of NHLBI, led by Dr. Gerald Hart (Biological Chemistry).

Proteome characterization center: a genoproteomics pipeline for cancer biomarkers 



PI: Chan D, Zhang H, Zhang Z

Role: Co-Principal Investigator

This is a center in Clinical Proteomic Tumor Analysis Consortium (CPTAC). The major goal of this Center is the proteomic characterization of cancer tissues and plasma samples with genomic data to not only verify the genomic alterations at the protein level but also allow for the analysis of unique features that are inherent to proteins including post-translational modification

Clinical and analytical validation of cancer biomarkers



PI: Chan, Daniel

Role: Co-investigator/developmental project leader 

Notes: This is a biomarker reference laboratory (BRL) of the Early Detection Research Network (EDRN). The major goal of this project is to conduct analytical and clinical validation studies of biomarkers. 

Glycoconjugates and cardiovascular disease



PI: Hart, Gerald

Role: Principal Investigator for project #4

Co-Principal Investigator (with Van Eyk) for mass spectrometry core

This is a center of Programs of Excellence in Glycosciences (PEG). The central theme of this center is the roles of both extracellular and intracellular glycoconjugates in the mechanisms protecting the heart or leading to atherosclerosis and cardiomyopathies, culminating in myocardial infarction and heart failure.



Mechanism and anti-cancer activity of SCFA-hexosamine analogs 



PI: Yarema, Kevin

Role: Co-investigator

The goal of the parent grant to this project is to develop novel sugar-based cancer drugs to treat metastatic cancer.



Johns Hopkins proteomic innovation center in heart failure

HHSN268201000032C (N01-HV-00240)


PI: Van Eyk, Jennifer

Role: Co-investigator

This is a center of NHLBI Proteomics Centers. The goal of this project is to develop and apply innovative mass spectrometry based PTM capture methods in heart failure. In particular, my project will focus on glycoproteome tools in both tissue and blood samples.


bottom of page